Defenders of the new screening policy argue that it provides critical data to optimize troop performance and health. Proponents within the Pentagon and among veterans' groups say the military has long relied on routine blood tests for various markers, and testosterone is no different. They point to rising rates of low testosterone among younger men, which can contribute to fatigue, depression, and decreased muscle mass—factors that could impair combat readiness.
Supporters also argue that early detection allows for interventions ranging from lifestyle changes to hormone therapy, potentially extending service members' careers and improving quality of life. The policy, they say, treats testosterone levels as another vital sign, similar to cholesterol or blood glucose. Mandatory screenings ensure no one slips through the cracks, especially those in high-stress roles where undiagnosed low testosterone could pose safety risks.
Another key argument is consistency. The military already mandates vaccinations, fitness tests, and health assessments. Adding a hormone screening is a logical extension of that accountability framework. Furthermore, the data collected could inform broader public health initiatives for veterans and the general population, as military studies often precede civilian guidelines.
Secretary Hegseth has emphasized that the screenings are voluntary in the sense that they involve blood draws, but refusal carries consequences—a stance supporters see as necessary for compliance. They believe that a force-wide baseline will help the military identify trends, allocate resources, and ultimately ensure that every soldier is physically and mentally prepared for the demands of service. For them, the policy is a proactive, science-backed move that prioritizes readiness over discomfort with the test itself.